Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and aldosterone and catecholamine excretion.
D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D001835:Body Weight; D002752:Chlorthalidone / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004837:Epinephrine / Q000652:urine; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D007741:Labetalol / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine; D011188:Potassium / Q000097:blood; D011674:Pulse / Q000187:drug effects; D012083:Renin / Q000097:blood
D004983:Ethanolamines; D000450:Aldosterone; D012083:Renin; D002752:Chlorthalidone; D007741:Labetalol; D011188:Potassium; D009638:Norepinephrine; D004837:Epinephrine